The Arab Drug Company Statistics
Total Valuation
EGX:ADCI has a market cap or net worth of EGP 899.70 million. The enterprise value is 1.31 billion.
Market Cap | 899.70M |
Enterprise Value | 1.31B |
Important Dates
The next estimated earnings date is Thursday, May 29, 2025.
Earnings Date | May 29, 2025 |
Ex-Dividend Date | Oct 28, 2024 |
Share Statistics
EGX:ADCI has 6.00 million shares outstanding. The number of shares has increased by 7.67% in one year.
Current Share Class | n/a |
Shares Outstanding | 6.00M |
Shares Change (YoY) | +7.67% |
Shares Change (QoQ) | +39.86% |
Owned by Insiders (%) | 4.60% |
Owned by Institutions (%) | n/a |
Float | 1.51M |
Valuation Ratios
The trailing PE ratio is 7.31.
PE Ratio | 7.31 |
Forward PE | n/a |
PS Ratio | 0.97 |
PB Ratio | 1.79 |
P/TBV Ratio | 1.79 |
P/FCF Ratio | 26.65 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.74, with an EV/FCF ratio of 38.70.
EV / Earnings | 10.62 |
EV / Sales | 1.41 |
EV / EBITDA | 6.74 |
EV / EBIT | 7.39 |
EV / FCF | 38.70 |
Financial Position
The company has a current ratio of 1.46, with a Debt / Equity ratio of 1.01.
Current Ratio | 1.46 |
Quick Ratio | 0.71 |
Debt / Equity | 1.01 |
Debt / EBITDA | 2.62 |
Debt / FCF | 15.06 |
Interest Coverage | 4.28 |
Financial Efficiency
Return on equity (ROE) is 31.34% and return on invested capital (ROIC) is 11.61%.
Return on Equity (ROE) | 31.34% |
Return on Assets (ROA) | 9.73% |
Return on Invested Capital (ROIC) | 11.61% |
Return on Capital Employed (ROCE) | 22.53% |
Revenue Per Employee | 809,891 |
Profits Per Employee | 107,138 |
Employee Count | 1,148 |
Asset Turnover | 0.82 |
Inventory Turnover | 2.25 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +64.38% in the last 52 weeks. The beta is 0.62, so EGX:ADCI's price volatility has been lower than the market average.
Beta (5Y) | 0.62 |
52-Week Price Change | +64.38% |
50-Day Moving Average | 141.69 |
200-Day Moving Average | 108.22 |
Relative Strength Index (RSI) | 74.40 |
Average Volume (20 Days) | 2,226 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, EGX:ADCI had revenue of EGP 929.75 million and earned 122.99 million in profits. Earnings per share was 20.50.
Revenue | 929.75M |
Gross Profit | 350.08M |
Operating Income | 176.89M |
Pretax Income | 184.60M |
Net Income | 122.99M |
EBITDA | 192.87M |
EBIT | 176.89M |
Earnings Per Share (EPS) | 20.50 |
Balance Sheet
The company has 101.57 million in cash and 508.28 million in debt, giving a net cash position of -406.71 million or -67.79 per share.
Cash & Cash Equivalents | 101.57M |
Total Debt | 508.28M |
Net Cash | -406.71M |
Net Cash Per Share | -67.79 |
Equity (Book Value) | 501.51M |
Book Value Per Share | 83.59 |
Working Capital | 197.58M |
Cash Flow
In the last 12 months, operating cash flow was 124.16 million and capital expenditures -90.40 million, giving a free cash flow of 33.76 million.
Operating Cash Flow | 124.16M |
Capital Expenditures | -90.40M |
Free Cash Flow | 33.76M |
FCF Per Share | 5.63 |
Margins
Gross margin is 37.65%, with operating and profit margins of 19.03% and 15.40%.
Gross Margin | 37.65% |
Operating Margin | 19.03% |
Pretax Margin | 19.86% |
Profit Margin | 15.40% |
EBITDA Margin | 20.74% |
EBIT Margin | 19.03% |
FCF Margin | 3.63% |
Dividends & Yields
This stock pays an annual dividend of 8.35, which amounts to a dividend yield of 5.57%.
Dividend Per Share | 8.35 |
Dividend Yield | 5.57% |
Dividend Growth (YoY) | 85.56% |
Years of Dividend Growth | 1 |
Payout Ratio | 36.77% |
Buyback Yield | -7.67% |
Shareholder Yield | -2.11% |
Earnings Yield | 13.67% |
FCF Yield | 3.75% |
Stock Splits
The last stock split was on December 30, 2010. It was a forward split with a ratio of 1.5.
Last Split Date | Dec 30, 2010 |
Split Type | Forward |
Split Ratio | 1.5 |
Scores
EGX:ADCI has an Altman Z-Score of 2.39. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.39 |
Piotroski F-Score | n/a |